EdgarLookup

Akebia Therapeutics, Inc. — All Filings

858 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 4 4/A 424B3 424B4 424B5 425 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A DEFR14A DRS DRS/A EFFECT FWP NT 10-K NT 10-Q POS AM POSASR PRE 14A PRER14A S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SCHEDULE 13G/A 0000102909-26-000566 Mar 26, 2026
4 PRIMARY DOCUMENT 0001591467-26-000003 Mar 5, 2026 Mar 4, 2026
10-K 10-K 0001517022-26-000020 Feb 26, 2026 Dec 31, 2025
8-K 8-K 0001517022-26-000019 Feb 26, 2026
4 PRIMARY DOCUMENT 0002007730-26-000002 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0001661887-26-000002 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0001619834-26-000002 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0002107264-26-000006 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0001762507-26-000002 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0001591467-26-000002 Feb 4, 2026 Feb 2, 2026
4 PRIMARY DOCUMENT 0001661887-26-000001 Feb 3, 2026 Jan 30, 2026
4 PRIMARY DOCUMENT 0001619834-26-000001 Feb 3, 2026 Jan 30, 2026
4 PRIMARY DOCUMENT 0002107264-26-000005 Feb 3, 2026 Jan 30, 2026
4 PRIMARY DOCUMENT 0002007730-26-000001 Feb 3, 2026 Jan 30, 2026
4 PRIMARY DOCUMENT 0001762507-26-000001 Feb 3, 2026 Jan 30, 2026
4 PRIMARY DOCUMENT 0001591467-26-000001 Feb 3, 2026 Jan 30, 2026
3 PRIMARY DOCUMENT 0002107264-26-000004 Feb 3, 2026 Jan 26, 2026
144 0001517022-26-000013 Feb 2, 2026
144 0001517022-26-000012 Feb 2, 2026
144 0001517022-26-000011 Feb 2, 2026
144 0001517022-26-000010 Feb 2, 2026
144 0001517022-26-000009 Feb 2, 2026
8-K 8-K 0001517022-26-000008 Jan 30, 2026 Jan 27, 2026
SCHEDULE 13G/A 0002012383-26-000635 Jan 21, 2026
8-K 8-K 0001517022-26-000003 Jan 12, 2026
8-K 8-K 0001517022-25-000051 Dec 1, 2025 Nov 28, 2025
8-K 8-K 0001517022-25-000048 Nov 17, 2025 Nov 12, 2025
10-Q 10-Q 0001517022-25-000046 Nov 10, 2025 Sep 30, 2025
8-K 8-K 0001517022-25-000045 Nov 10, 2025
8-K 8-K 0001517022-25-000040 Oct 28, 2025
S-8 S-8 0001193125-25-175015 Aug 7, 2025
10-Q 10-Q 0001628280-25-038600 Aug 7, 2025 Jun 30, 2025
8-K 8-K 0001517022-25-000034 Aug 7, 2025
4 PRIMARY DOCUMENT 0001562180-25-005201 Jul 1, 2025 Jun 30, 2025
144 0001517022-25-000031 Jun 30, 2025
8-K 8-K 0001517022-25-000030 Jun 13, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004724 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004723 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004722 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004721 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004720 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004719 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004718 Jun 11, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0001562180-25-004717 Jun 11, 2025 Jun 9, 2025
4 PRIMARY DOCUMENT 0001562180-25-004491 Jun 5, 2025 Jun 4, 2025
10-Q 10-Q 0001628280-25-023460 May 8, 2025 Mar 31, 2025
8-K 8-K 0001517022-25-000027 May 8, 2025
SCHEDULE 13G 0000932471-25-000479 Apr 30, 2025
ARS ARS 0001517022-25-000025 Apr 29, 2025
DEFA14A DEFA14A 0001517022-25-000024 Apr 29, 2025